艾昆纬(IQVIA)

最新新闻

• 评级变动
  Analysts Conflicted on These Healthcare Names: IQVIA Holdings (IQV) and Fortrea Holdings Inc. (FTRE)
  TipRanks · 2026/7/29
• 评级变动
  Barclays Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $210
  \u5e02\u573a\u8d44\u8baf · 2026/6/24
• 评级变动
  RBC Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $221
  \u5e02\u573a\u8d44\u8baf · 2026/7/9
• 评级变动
  Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/6/29
• 评级变动
  Morgan Stanley Maintains IQVIA Holdings(IQV.US) With Hold Rating, Raises Target Price to $225
  \u5e02\u573a\u8d44\u8baf · 2026/6/18
• RBC Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $319
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  Truist Financial Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $329
  \u5e02\u573a\u8d44\u8baf · 2026/9/28
• Mizuho Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $300
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  UBS Initiates IQVIA Holdings(IQV.US) With Buy Rating, Announces Target Price $345
  \u5e02\u573a\u8d44\u8baf · 2026/9/30
• 评级变动
  A Quick Look at Today's Ratings for IQVIA Holdings(IQV.US), With a Forecast Between $270 to $300
  \u5e02\u573a\u8d44\u8baf · 2026/7/30
• 评级变动
  RBC Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $319
  \u5e02\u573a\u8d44\u8baf · 2026/9/29
• Olorofim Vs. AmBisome: A Phase III Antifungal Trial With Implications for IQVIA Holdings (IQV)
  TipRanks · 2026/10/9
• 评级变动
  Baird Maintains IQVIA Holdings(IQV.US) With Buy Rating, Cuts Target Price to $249
  \u5e02\u573a\u8d44\u8baf · 2026/7/1
• 评级变动
  HSBC Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $240
  \u5e02\u573a\u8d44\u8baf · 2026/7/6
• Barclays Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $300
  \u5e02\u573a\u8d44\u8baf · 2026/10/7
• 评级变动
  A Quick Look at Today's Ratings for IQVIA Holdings(IQV.US), With a Forecast Between $240 to $300
  \u5e02\u573a\u8d44\u8baf · 2026/7/29
• 评级变动
  Evercore Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $275
  \u5e02\u573a\u8d44\u8baf · 2026/8/12
• 评级变动
  Mizuho Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $230
  \u5e02\u573a\u8d44\u8baf · 2026/7/13
• 评级变动
  Morgan Stanley Maintains IQVIA Holdings(IQV.US) With Hold Rating, Raises Target Price to $270
  \u5e02\u573a\u8d44\u8baf · 2026/9/17
• BofA Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Raises Target Price to $305
  \u5e02\u573a\u8d44\u8baf · 2026/10/9
• 评级变动
  HSBC Maintains IQVIA Holdings(IQV.US) With Buy Rating, Cuts Target Price to $210
  \u5e02\u573a\u8d44\u8baf · 2026/6/3
• 评级变动
  BofA Securities Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $245
  \u5e02\u573a\u8d44\u8baf · 2026/5/14
• 评级变动
  BMO Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Cuts Target Price to $210
  \u5e02\u573a\u8d44\u8baf · 2026/5/7
• 评级变动
  Morgan Stanley Downgrades IQVIA Holdings(IQV.US) to Hold Rating, Cuts Target Price to $200
  \u5e02\u573a\u8d44\u8baf · 2026/6/17
• 评级变动
  BMO Capital Maintains IQVIA Holdings(IQV.US) With Buy Rating, Maintains Target Price $210
  \u5e02\u573a\u8d44\u8baf · 2026/5/8

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。